Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer
Authors
Keywords
Glutamine, PET, SLC1A5, ASCT2, Transporter, NSCLC, SCC, Lung, Cancer
Journal
MOLECULAR IMAGING AND BIOLOGY
Volume 18, Issue 1, Pages 18-23
Publisher
Springer Nature
Online
2015-05-13
DOI
10.1007/s11307-015-0862-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency
- (2015) Michael L. Schulte et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer
- (2015) Mohamed Hassanein et al. INTERNATIONAL JOURNAL OF CANCER
- Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
- (2015) Sriram Venneti et al. Science Translational Medicine
- A Peptide-Based Positron Emission Tomography Probe for In Vivo Detection of Caspase Activity in Apoptotic Cells
- (2014) M. R. Hight et al. CLINICAL CANCER RESEARCH
- Accuracy of FDG-PET to Diagnose Lung Cancer in Areas With Infectious Lung Disease
- (2014) Stephen A. Deppen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- First Clinical Results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma
- (2014) I. A. Burger et al. JOURNAL OF NUCLEAR MEDICINE
- [18F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
- (2014) Zehui Wu et al. MOLECULAR PHARMACEUTICS
- Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
- (2013) Brenda K. Edwards et al. CANCER
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Resistant Disease
- (2013) Kadoaki Ohashi et al. JOURNAL OF CLINICAL ONCOLOGY
- SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
- (2012) M. Hassanein et al. CLINICAL CANCER RESEARCH
- Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Accuracy of FDG-PET to Diagnose Lung Cancer in a Region of Endemic Granulomatous Disease
- (2011) Stephen Deppen et al. ANNALS OF THORACIC SURGERY
- Preparation and Characterization of L-[5-11C]-Glutamine for Metabolic Imaging of Tumors
- (2011) W. Qu et al. JOURNAL OF NUCLEAR MEDICINE
- Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
- (2011) D. Gaglio et al. Molecular Systems Biology
- Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling
- (2011) J. Chmielecki et al. Science Translational Medicine
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
- (2010) Jian-Bin Wang et al. CANCER CELL
- Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model
- (2010) Laura M. Shelton et al. INTERNATIONAL JOURNAL OF CANCER
- Synthesis of Optically Pure 4-Fluoro-Glutamines as Potential Metabolic Imaging Agents for Tumors
- (2010) Wenchao Qu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started